Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

LILRA4 Protein (His tag)

LILRA4 Spezies: Human Wirt: HEK-293 Cells Recombinant 90 %
Produktnummer ABIN7489015
  • Target Alle LILRA4 Proteine anzeigen
    LILRA4 (Leukocyte Immunoglobulin-Like Receptor, Subfamily A (With TM Domain), Member 4 (LILRA4))
    Protein-Typ
    Recombinant
    Spezies
    • 6
    • 1
    Human
    Quelle
    • 3
    • 2
    • 2
    HEK-293 Cells
    Aufreinigungstag / Konjugat
    Dieses LILRA4 Protein ist gelabelt mit His tag.
    Verwendungszweck
    Human LILRA4 / CD85g / ILT7 Protein, His Tag
    Sequenz
    Glu 24 - Asn 446
    Produktmerkmale
    Human LILRA4 Protein, His Tag is expressed from human 293 cells (HEK293). It contains AA Glu 24 - Asn 446 (Accession # P59901-1).
    Reinheit
    90 %
    Endotoxin-Niveau
    1.0 EU per μg
    Top Product
    Discover our top product LILRA4 Protein
  • Kommentare

    This protein carries a polyhistidine tag at the C-terminus. (10xHis) The protein has a calculated MW of 48.5 kDa. The protein migrates as 60-66 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Buffer
    PBS, pH 7.4
    Lagerung
    -20 °C
    Informationen zur Lagerung
    -20°C
  • Target
    LILRA4 (Leukocyte Immunoglobulin-Like Receptor, Subfamily A (With TM Domain), Member 4 (LILRA4))
    Andere Bezeichnung
    LILRA4 (LILRA4 Produkte)
    Synonyme
    ILT7 Protein, CD85g Protein, leukocyte immunoglobulin like receptor A4 Protein, LILRA4 Protein
    Hintergrund
    Leukocyte immunoglobulin-like receptor subfamily A member 4 (LILRA4/ILT7/CD85g) is a marker of plasmacytoid dendritic cells (pDCs), which are reported to be a major source of the abnormally high levels of IFNα associated with autoimmune diseases. Targeting LILRA4 with therapeutic antibodies to promote killing of these IFNα-producing pDCs is being investigated as a novel approach to alleviating the symptoms of autoimmune diseases. LILRA4 is an immunoglobulin-like protein preferentially expressed on the surface of human plasmacytoid dendritic cells (pDCs). It interacts with bone marrow stromal cell antigen 2 to control the Toll-like receptor (TLR) driven response by pDCs to viral infection. It may also be involved in modulating pDC-tumour interactions. pDCs are a source of the excess IFNα which drives autoimmune disease symptoms.
    Molekulargewicht
    48.5 kDa
Sie sind hier: